focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU gets 107 million vaccine doses by end of week; finds no Astra risk

Wed, 31st Mar 2021 14:53

(Alliance News) - EU member states will have received a total of 107 million doses of coronavirus vaccine by the end of this week, a European Commission spokeswoman said Wednesday.

Also, the EU's drug regulator said, experts probing links between the AstraZeneca PLC coronavirus vaccine and blood clots have found no specific risk factors, including age, but are carrying out further analysis.

"At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events," the European Medicines Agency said in a statement.

Deliveries for the first three months of the year are made up of 67.2 million doses from BioNtech SE-Pfizer Inc, 29.8 million from Astra, and 9.8 million from Moderna Inc, the commission said. 

The overall figure was revised down dramatically after the Anglo-Swedish pharma giant AstraZeneca slashed the number it was providing from a contracted 120 million doses.

The production shortfall has contributed to a stuttering start to the EU's vaccination campaign that has seen the bloc lag behind countries including the US, Britain, and Israel.

Deliveries are expected to pick up considerably in the second quarter of the year, with the commission saying it should receive at least 300 million doses by the end of June.

That figure should include 55 million shots of the single-dose Johnson & Johnson jab, which officials hope will help speed up vaccination rates. 

EU chief Ursula von der Leyen insists the 27-nation bloc remains on course to meet a target to inoculate 70% of adults "by the end of summer". 

That is despite it being set to miss another stated ambition to have 80% of over-80s and health workers vaccinated by the end of March. 

The shortfall in deliveries from AstraZeneca has led to a row with Britain, as both sides scramble to ensure they get doses. 

Von der Leyen warned last week that the bloc would ban drug firms exporting vaccines until they made good on promised deliveries to the EU. 

There have also been calls from five member states led by Austria for some doses to be redistributed within the EU over fears of shortfalls in some capitals. 

On Tuesday, Austria said it had become the latest EU country to open talks with Russia about securing deliveries of its Sputnik V vaccine.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.